协和马东来教授7篇NEJM、2篇JAMA和2篇Lancet病例的大神

2019-12-24 iNature iNature

2019年6月22日,北京协和医学院马东来团队在国际顶级医学期刊Lancet(IF=59)再次发表题为“Atypical presentation of classic Kaposi's sarcoma”的案例分析,该案例具体介绍如下: 一名77岁的女性在马东来的部门就诊,她的左乳房上有多处疼痛的紫色病变2年。体格检查显示左乳腺,颈部,前臂,腿部,手部和足部有多处,紫罗兰,浸润性丘疹,结节和

2019年6月22日,北京协和医学院马东来团队在国际顶级医学期刊Lancet(IF=59)再次发表题为“Atypical presentation of classic Kaposi's sarcoma”的案例分析,该案例具体介绍如下:

一名77岁的女性在马东来的部门就诊,她的左乳房上有多处疼痛的紫色病变2年。体格检查显示左乳腺,颈部,前臂,腿部,手部和足部有多处,紫罗兰,浸润性丘疹,结节和斑块。她还患有腋窝和腹股沟淋巴结肿大

文章总结:经典的Kaposi肉瘤呈现在非典型患者身上

在此问题之前,她没有病史。生化分析结果正常,患者为HIV和巨细胞病毒血清阴性 CT扫描正常,内镜检查和结肠镜检查未见肠道受累。取自左侧乳房的皮肤活检标本显示梭形细胞肿瘤,CD34和人类疱疹病毒8(HHV-8)的免疫组织化学染色呈阳性,后者通常被称为与疱疹病毒相关的卡波西氏肉瘤 - 确认了Kaposi肉瘤的诊断。患者被转诊到肿瘤科门诊进行进一步治疗。

乍一看题目,我想很多朋友会问:这怎么可能?这里我们回答一下:这些都是个案或comment等,并非Article。那么,这个作者到底是谁呢?没错,就是北京协和医院的马东来博士(教授,主任医师,博士生导师)。

北京协和医院以诊治疑难杂症为特色,这些个案报道难道不也是一个写照吗?将总结的经验分享出来,给全世界的医生做参考。我们觉得也是也重要的!不比做基础的贡献小!

我们以((Dong-lai Ma[Author]) OR (Ma DL[Author])) AND Peking Union Medical College Hospital [Affiliation] 为检索,Pubmed结果显示:

据马教授介绍,文章投稿后需经过几大关:主编筛选、栏目主编筛选、月度阶段性集中筛选,这些流程进行完约需6~8个月,此时还幸存的文章才有机会送外审,外审后仍有可能被拒。如此复杂且苛刻的遴选程序,才能保证做到优中选优。文章发表周期也因此较长,一般在一年左右。

发表一篇文章如此困难,马教授多年的投稿历程也充满艰难和坎坷。他从2008年就开始向这个栏目投稿,连续被拒稿12篇,但他没有在挫折中轻易放弃,而是不断总结经验,继续写作和投稿,直到2013年才终于发表了第一篇文章。

在写作方面,该栏目投稿要求字数控制在150个单词内,作者不超过2位。

马东来教授通过分享他在文章发表历程中的切实体会,总结了几条发表经验。一是平时要注重临床资料的收集和整理。二是要做好随访工作,对好的病例一定要及时跟踪,定期随诊。三是注重合作和积累经验。

笔者也曾经遇到过一个比较特殊的病例,结果试水NEJM、Lancet后无果,后再投稿,最终也只发了一个2~3分的case report。

我们私自认为,case report在临床工作中是必不可少的,尽管目前各种绩效以及晋升用不上,但对于提升个人的临床实践技能还是有用处的。

另外,我们来检索一下国人已经发表在NEJM、Lancet、JAMA等三大期刊上的case report的文章:以China作为Affiliation(按照国人的习惯,单位中都会写China,一般国际合作的case report很少)。当然,这样会漏掉一部分case report,比如Lancet的clinical picture等栏目,其实也是case report。

我们可以看到,上述方法能检索到43篇NEJM、41篇Lancet、12篇JAMA。如果再加上Lancet的clinical picture等,应该会更多。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1830384, encodeId=8fd51830384ac, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Mar 06 18:47:00 CST 2020, time=2020-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1389922, encodeId=47d6138992226, content=<a href='/topic/show?id=6150359e0f4' target=_blank style='color:#2F92EE;'>#协和#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35970, encryptionId=6150359e0f4, topicName=协和)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2c92500045, createdName=12498636m49(暂无昵称), createdTime=Thu Dec 26 08:47:00 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377387, encodeId=c0823e738740, content=大神, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=090d49833, createdName=LaserDermatol, createdTime=Tue Dec 24 23:04:17 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035061, encodeId=9b4010350613e, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Tue Dec 24 20:47:00 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035836, encodeId=6272103583690, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Tue Dec 24 20:47:00 CST 2019, time=2019-12-24, status=1, ipAttribution=)]
    2020-03-06 howi
  2. [GetPortalCommentsPageByObjectIdResponse(id=1830384, encodeId=8fd51830384ac, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Mar 06 18:47:00 CST 2020, time=2020-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1389922, encodeId=47d6138992226, content=<a href='/topic/show?id=6150359e0f4' target=_blank style='color:#2F92EE;'>#协和#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35970, encryptionId=6150359e0f4, topicName=协和)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2c92500045, createdName=12498636m49(暂无昵称), createdTime=Thu Dec 26 08:47:00 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377387, encodeId=c0823e738740, content=大神, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=090d49833, createdName=LaserDermatol, createdTime=Tue Dec 24 23:04:17 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035061, encodeId=9b4010350613e, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Tue Dec 24 20:47:00 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035836, encodeId=6272103583690, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Tue Dec 24 20:47:00 CST 2019, time=2019-12-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1830384, encodeId=8fd51830384ac, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Mar 06 18:47:00 CST 2020, time=2020-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1389922, encodeId=47d6138992226, content=<a href='/topic/show?id=6150359e0f4' target=_blank style='color:#2F92EE;'>#协和#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35970, encryptionId=6150359e0f4, topicName=协和)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2c92500045, createdName=12498636m49(暂无昵称), createdTime=Thu Dec 26 08:47:00 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377387, encodeId=c0823e738740, content=大神, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=090d49833, createdName=LaserDermatol, createdTime=Tue Dec 24 23:04:17 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035061, encodeId=9b4010350613e, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Tue Dec 24 20:47:00 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035836, encodeId=6272103583690, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Tue Dec 24 20:47:00 CST 2019, time=2019-12-24, status=1, ipAttribution=)]
    2019-12-24 LaserDermatol

    大神

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1830384, encodeId=8fd51830384ac, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Mar 06 18:47:00 CST 2020, time=2020-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1389922, encodeId=47d6138992226, content=<a href='/topic/show?id=6150359e0f4' target=_blank style='color:#2F92EE;'>#协和#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35970, encryptionId=6150359e0f4, topicName=协和)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2c92500045, createdName=12498636m49(暂无昵称), createdTime=Thu Dec 26 08:47:00 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377387, encodeId=c0823e738740, content=大神, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=090d49833, createdName=LaserDermatol, createdTime=Tue Dec 24 23:04:17 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035061, encodeId=9b4010350613e, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Tue Dec 24 20:47:00 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035836, encodeId=6272103583690, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Tue Dec 24 20:47:00 CST 2019, time=2019-12-24, status=1, ipAttribution=)]
    2019-12-24 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1830384, encodeId=8fd51830384ac, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Mar 06 18:47:00 CST 2020, time=2020-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1389922, encodeId=47d6138992226, content=<a href='/topic/show?id=6150359e0f4' target=_blank style='color:#2F92EE;'>#协和#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35970, encryptionId=6150359e0f4, topicName=协和)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e2c92500045, createdName=12498636m49(暂无昵称), createdTime=Thu Dec 26 08:47:00 CST 2019, time=2019-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377387, encodeId=c0823e738740, content=大神, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=090d49833, createdName=LaserDermatol, createdTime=Tue Dec 24 23:04:17 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035061, encodeId=9b4010350613e, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Tue Dec 24 20:47:00 CST 2019, time=2019-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035836, encodeId=6272103583690, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Tue Dec 24 20:47:00 CST 2019, time=2019-12-24, status=1, ipAttribution=)]
    2019-12-24 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0